Onto Innovation IncOnto closed its $720M purchase of a 27% Rigaku stake, building on their X-ray chip-tool collaboration.
Onto Innovation closed its purchase of a 27% minority stake in Rigaku Holdings Corporation for roughly $720 million, buying the shares from Atom Investment, L.P., an affiliate of Carlyle, on August 10. The deal builds on a collaboration announced in April to develop X-ray-based tools for chip manufacturing, and comes four days after Onto reported record second-quarter revenue of $343.1 million, up 35.3% year over year. Backlog crossed $1 billion for the first time, and the company guided third-quarter revenue to $380–400 million with non-GAAP EPS of $2.18–$2.38. However, first-half net income fell to $93.9 million from $98.0 million, and GAAP operating margin dropped to 15.3% from 18.3%, as costs climbed. The Rigaku stake will be booked under the fair value option method, giving Onto one board seat but no consolidation, a large sum for limited control.
Onto Innovation IncOnto closed its $720M purchase of a 27% Rigaku stake, building on their X-ray chip-tool collaboration.
Rigaku gains Onto as a 27% minority shareholder for ~$720M and a board seat.
Carlyle Group IncCarlyle affiliate Atom Investment sold its Rigaku stake to Onto, a portfolio exit for Carlyle.